Table 3 Treatment data and outcome
Treat-ment time [min] [19] | Serum bilirubin [mg/dl] | Serum creatinine [mg/dl] | Serum BUN [mg/dl] | No. of treatments | 28d survival | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Day before ADVOS | Before start of ADVOS | After ADVOS | Delta [mg/dl] | Day before ADVOS | Before start of ADVOS | After ADVOS | Delta [mg/dl] | Day before ADVOS | Before start of ADVOS | After ADVOS | Delta [mg/dl] | ||||
Patient | |||||||||||||||
P1 | 745 | 37.4 | 41.1 | 25.4 | −15.7 | 0.7 | 0.8 | 0.5 | −0.3 | 59 | 76 | 28 | −48 | 19 | - |
P2 | 800 | 22.8 | 24.0 | 12.8 | −11.2 | 1.0 | 1.0 | 0.9 | −0.1 | 26 | 25 | 14 | −11 | 10 | - |
P3 | 730 | 20.8 | 22.3 | 14.1 | −8.2 | 1.8 | 1.6 | 1.5 | −0.1 | 21 | 20 | 18 | −2 | 7 | - |
P4 | 770 | 16.3 | 15.9 | 13.2 | −2.7 | 2.4 | 1.9 | 1.5 | −0.4 | 27 | 20 | 18 | −2 | 29 | - |
P5 | 800 | n.d. | 11.6 | 9.2 | −2.4 | n.d. | 2.8 | 1.2 | −1.6 | n.d. | 45 | 13 | −32 | 3 | - |
P6 | 600 | 43.5 | 41.6 | 34.2 | −7.4 | 3.9 | 3.3 | 2.2 | −1.1 | 91 | 97 | 63 | −34 | 22 | + |
P7 | 720 | 3.1 | 5.3 | 3.9 | −1.4 | 1.7 | 3.0 | 2.1 | −0.9 | 19 | 33 | 22 | −11 | 17 | + |
P8 | 420 | 21.6 | 20.7 | 17.8 | −2.9 | 1.3 | 2.0 | 2.8 | +0.8 | 44 | 69 | 82 | +13 | 9 | - |
P9 | 570 | 26.4 | 26.2 | 20.3 | −5.9 | 1.9 | 2.3 | 1.7 | −0.6 | 43 | 51 | 35 | −16 | 6 | + |
P10 | 300 | 1.9 | 2.0 | 1.5 | −0.5 | 1.7 | 1.3 | 0.7 | −0.6 | 54 | 31 | 16 | −15 | 1 | - |
P11 | 240 | 40.4 | 41.6 | 29.0 | −12.6 | 3.0 | 3.2 | 2.0 | −01.2 | 35 | 40 | 27 | −13 | 101 | + |
P12 | 510 | 18.3 | 17.5 | 10.9 | −6.6 | 1.4 | 2.9 | 2.1 | −0.8 | 40 | 49 | 27 | −22 | 3 | - |
P13 | 360 | 38.2 | 42.1 | 19.9 | −22.2 | 3.0 | 2.3 | 1.2 | −1.1 | 79 | 68 | 33 | −35 | 11 | + |
P14 | 480 | 49.3 | 51.8 | 35.7 | −16.1 | 3.0 | 3.0 | 2.2 | −0.8 | 54 | 67 | 39 | −28 | 1 | - |
Mean ± SD Number [%] | 575± 193 | 26.2± 14.9 | 26.0± 15.4 | 17.7± 10.5 | −8.3± 6.5 | 2.0± 0.9 | 2.2± 0.8 | 1.6± 0.7 | −0.6± 0.6 | 46± 22 | 49± 23 | 31± 20 | −18± 16 | 17± 26 [1–101] | 5/14 [36%] |